COVID-19 Vaccine Update
Everyone is eagerly awaiting a cure or vaccine for Coronavirus (COVID-19). Most people infected with this disease will experience respiratory, kidney, liver, and heart problems. Due to this virus, over 1.29 million people have already died worldwide, and elders and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illnesses. Although there are many
patients who have recovered from COVID-19, scientists all over the world are putting effort to create a vaccine that can prevent and save lives.
According to BioNTech, a biotech company that creates vaccines, their vaccine against COVID-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement and relief in the face of the global pandemic. The vaccine is the first to be tested in the United States to generate late-stage data. The companies said an early analysis of the results showed that individuals who received two injections of the vaccine three weeks apart experienced more than 90% fewer cases of symptomatic Covid-19 than those who received a placebo. For months, researchers have cautioned that a vaccine that might only be 60% or 70% effective. In addition, Pfizer’s BNT 162 and Moderna’s mRNA-1273 have shown 90% efficacy. The government has said that they will start initiating hospitals to schedule people’s vaccine shots on December 13.
It seems like the vaccine will come out somewhat close to being perfect in early 2021. We have all waited for this moment as we endured social distancing, closures, and quarantine; however, a safe return to normalcy seems to be just around the
corner as we look to the new year.